• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The response pattern to SSRIs as assessed by the Montgomery-Åsberg Depression Rating Scale: a patient-level meta-analysis.

作者信息

Hieronymus Fredrik, Lisinski Alexander, Østergaard Søren Dinesen, Eriksson Elias

机构信息

Department of Pharmacology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

出版信息

World Psychiatry. 2022 Oct;21(3):472-473. doi: 10.1002/wps.21029.

DOI:10.1002/wps.21029
PMID:36073711
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9453909/
Abstract
摘要

相似文献

1
The response pattern to SSRIs as assessed by the Montgomery-Åsberg Depression Rating Scale: a patient-level meta-analysis.蒙哥马利-阿斯伯格抑郁评定量表评估的对选择性5-羟色胺再摄取抑制剂（SSRI）的反应模式：一项患者水平的荟萃分析。
World Psychiatry. 2022 Oct;21(3):472-473. doi: 10.1002/wps.21029.
2
Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials.新一代抗抑郁药在蒙哥马利-阿斯伯格抑郁评定量表（金标准临床医生评定量表）评估中的疗效：一项随机安慰剂对照试验的荟萃分析。
PLoS One. 2020 Feb 26;15(2):e0229381. doi: 10.1371/journal.pone.0229381. eCollection 2020.
3
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.一项关于喹硫平治疗双相I型或II型抑郁症的随机、双盲、安慰剂对照试验。
Am J Psychiatry. 2005 Jul;162(7):1351-60. doi: 10.1176/appi.ajp.162.7.1351.
4
Rating depression severity in the elderly physically ill patient: reliability and factor structure of the Hamilton and the Montgomery-Asberg Depression Rating Scales.评估老年躯体疾病患者的抑郁严重程度：汉密尔顿抑郁量表和蒙哥马利-艾森伯格抑郁评定量表的信度和因子结构
Int J Geriatr Psychiatry. 1998 Apr;13(4):257-61. doi: 10.1002/(sici)1099-1166(199804)13:4<257::aid-gps773>3.0.co;2-u.
5
Symptom predictors of response to electroconvulsive therapy in older patients with treatment-resistant depression.老年难治性抑郁症患者电抽搐治疗反应的症状预测因子。
Int J Gen Med. 2011;4:515-9. doi: 10.2147/IJGM.S21029. Epub 2011 Jul 8.
6
An item response theory evaluation of the young mania rating scale and the montgomery-asberg depression rating scale in the systematic treatment enhancement program for bipolar disorder (STEP-BD).双相情感障碍系统治疗强化项目（STEP-BD）中对青年躁狂评定量表和蒙哥马利-阿斯伯格抑郁评定量表的项目反应理论评估。
J Affect Disord. 2016 Nov 15;205:73-80. doi: 10.1016/j.jad.2016.06.062. Epub 2016 Jul 13.
7
Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients.新型五肽抗抑郁药奈米非肽治疗重度抑郁难治性患者的临床疗效
Int Clin Psychopharmacol. 2008 Jan;23(1):29-35. doi: 10.1097/YIC.0b013e32817396c2.
8
The comparison of Montgomery and Asberg Depression Rating Scale (MADRS thai) to diagnostic and statistical manual of mental disorders (DSM) and to Hamilton Rating Scale for Depression (HRSD): validity and reliability.蒙哥马利-阿斯伯格抑郁评定量表（泰国版MADRS）与《精神疾病诊断与统计手册》（DSM）及汉密尔顿抑郁评定量表（HRSD）的比较：效度与信度
J Med Assoc Thai. 2007 Mar;90(3):524-31.
9
Can nurses help identify patients with depression following stroke? A pilot study using two methods of detection.护士能否帮助识别中风后患有抑郁症的患者？一项使用两种检测方法的试点研究。
J Adv Nurs. 2007 Mar;57(5):505-12. doi: 10.1111/j.1365-2648.2006.04135.x.
10
Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale.蒙哥马利-艾斯伯格抑郁评定量表波斯语版本的效度和重测信度。
Neuropsychiatr Dis Treat. 2016 Mar 7;12:603-7. doi: 10.2147/NDT.S103869. eCollection 2016.

引用本文的文献

1
Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.裸盖菇素、选择性5-羟色胺再摄取抑制剂（SSRI）或艾司氯胺酮治疗抑郁症试验中的对照组结果：一项荟萃分析。
JAMA Netw Open. 2025 Jul 1;8(7):e2524119. doi: 10.1001/jamanetworkopen.2025.24119.
2
Impact of sedative and appetite-increasing properties on the apparent antidepressant efficacy of mirtazapine, selective serotonin reuptake inhibitors and amitriptyline: an item-based, patient-level meta-analysis.镇静及增加食欲特性对米氮平、选择性5-羟色胺再摄取抑制剂和阿米替林抗抑郁疗效的影响：一项基于项目的患者水平荟萃分析。
EClinicalMedicine. 2024 Nov 7;77:102904. doi: 10.1016/j.eclinm.2024.102904. eCollection 2024 Nov.

本文引用的文献

1
Do side effects of antidepressants impact efficacy estimates based on the Hamilton Depression Rating Scale? A pooled patient-level analysis.抗抑郁药的副作用是否会影响基于汉密尔顿抑郁评定量表的疗效评估？一项汇总的患者水平分析。
Transl Psychiatry. 2021 Apr 27;11(1):249. doi: 10.1038/s41398-021-01364-0.
2
Item-based analysis of the effects of duloxetine in depression: a patient-level post hoc study.基于项目的度洛西汀治疗抑郁症效果分析：一项患者水平的事后研究。
Neuropsychopharmacology. 2020 Feb;45(3):553-560. doi: 10.1038/s41386-019-0523-4. Epub 2019 Sep 14.
3
Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression.在抑郁症的选择性 5-羟色胺再摄取抑制剂试验中早期焦虑恶化的发生率。
Acta Psychiatr Scand. 2017 Oct;136(4):343-351. doi: 10.1111/acps.12784. Epub 2017 Aug 31.
4
Emotional blunting with antidepressant treatments: A survey among depressed patients.抗抑郁治疗导致的情感迟钝：对抑郁症患者的一项调查。
J Affect Disord. 2017 Oct 15;221:31-35. doi: 10.1016/j.jad.2017.05.048. Epub 2017 Jun 6.
5
The 52 symptoms of major depression: Lack of content overlap among seven common depression scales.重度抑郁症的52种症状：七种常见抑郁量表之间缺乏内容重叠。
J Affect Disord. 2017 Jan 15;208:191-197. doi: 10.1016/j.jad.2016.10.019. Epub 2016 Oct 21.
6
Simple options for improving signal detection in antidepressant clinical trials.改善抗抑郁药物临床试验中信号检测的简单方法。
Psychopharmacol Bull. 2007;40(2):101-14.
7
Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.使用另一种心理测量方法重新审视西酞普兰的剂量反应，以评估与安慰剂相比，四种固定剂量西酞普兰对重度抑郁症患者的临床疗效。
Psychopharmacology (Berl). 2002 Aug;163(1):20-5. doi: 10.1007/s00213-002-1147-6. Epub 2002 Jul 3.
8
The responsiveness of the Hamilton Depression Rating Scale.
J Psychiatr Res. 2000 Jan-Feb;34(1):3-10. doi: 10.1016/s0022-3956(99)00037-0.